Dr. Kadauke is the assistant director of the Cell and Gene Therapy Laboratory at CHOP, where he splits his time between developing GMP cell therapies and clinical data science. His research focuses on mitigation of adverse effects after CAR-T therapy and after blood and marrow transplantation.

Dr. Kalish's research focuses on understanding the molecular and epigenetic mechanisms that contribute to the predisposition to cancer that is characteristic of pediatric patients with rare imprinted gene disorders, including the overgrowth disorder Beckwith-Wiedemann syndrome (BWS).

Ellie Kaplan-Kahn, PhD is a postdoctoral fellow at the Center for Autism Research.

Minal Karamchandani is the radiology business manager.

Dr. Karmacharya is a biomedical researcher who works in the field of therapeutic ultrasound.

Dr. Kassam-Adams’ current research focuses on data sharing and data harmonization in traumatic stress research, and on the development and evaluation of tools that enable trauma-informed and family-centered care in pediatric health settings. Current National Institutes of Health-funded projects include an eHealth tool incorporating game-based screening of child symptoms and functioning, and online training for providers in non-pediatric emergency departments.

Dr. Katz’s investigates the sequelae of obesity and type 2 diabetes mellitus in youth. Her research involves the intersection of sleep, obesity, and glucose intolerance and prevention of cardiovascular risk. Her studies have led to the evaluation of quantitative tools important for assessment of metabolic risk in youth.

Dr. Kelly’s research career began with deciphering the genetic basis of inborn errors in metabolism in children, followed by a series of breakthrough discoveries relevant to the diagnosis and treatment of common forms of heart failure in the general population.

Dr. Kelsen’s research focus is on the genetic, immunologic, and microbiomic causes of very early onset inflammatory bowel disease. Through a multidisciplinary team approach, Dr. Kelsen and her colleagues perform genetic sequencing to identify causative genetic variants in children with VEO-IBD, study the function of these variants, and use this information to improve the clinical outcomes for these children.

Dr. Kennedy's current research focuses on epilepsy genetics and epilepsy surgery, including stereo-EEG, hemispherotomy, corpus callosotomy, and vagal nerve stimulation.

Dr. Kenyon's research focuses on integrating care systems and reducing outcome disparities for children with asthma. His recent work focuses on developing novel interventions to enhance asthma controller medication use in the highest risk children by leveraging mobile health technology and incentives oriented to the child.

Dr. Keren’s research focuses on the effectiveness and cost-effectiveness of treatments for common problems in general pediatrics, including the prediction and prevention of newborn hyperbilirubinemia (jaundice) and kernicterus (a complication of jaundice), the therapeutic and radiological management of children with urinary tract infections, and the epidemiology and economics of influenza.

Dr. Kersun has a strong interest in trainee education and collaborates with colleagues at Children's Hospital of Philadelphia and other institutions to develop innovative methods of teaching various topics in oncology. She also engages in collaborative research related to the communication of difficult news to patients.

Dr. Kessler is interested in the epileptic mechanisms of the human brain, specifically in children and the effect that transcranial magnetic stimulation has on those neural processes.

Vahid Khalkali is a research scientist for the Artificial Intelligence Program.

Dr. Eugene Khandros is a physician-scientist with a clinical and research focus on disorders of red blood cells and hemoglobin production.

Nick Kight facilitates seamless interactions with CHOP Research Information Systems (RIS) by promoting knowledge, accessibility, and user-friendly request and support methods for RIS applications and services.

Todd Kilbaugh, MD, is an anesthesiologist and pediatric intensivist with the Department of Anesthesiology and Critical Care Medicine, medical director of the ECMO Center, and director of the Resuscitation Science Center at Children's Hospital of Philadelphia. 

Dr. Kim conducts clinical evaluations for infants and school-age children for studies exploring language and development. Her work at the Center for Autism Research focuses on developing and implementing behavioral protocols to support children who are participating in neuroimaging research studies.

Ayana King-Pointer has enjoyed working at Children's Hospital of Philadelphia for many years, providing high-level administrative support to the scientific director, training director, and administrative director in the Center for Autism Research.

Dr. Kirschen’s research interest is pediatric neurocritical care. His work focuses on using multimodality neuromonitoring and neuroimaging to detect and prevent brain injury in critically ill children, predicting recovery after severe acute brain injury, and the accurate diagnosis of brain death.

Leads and evolves the technology and support services provided by Research Information Services to the Research Institute.

Dr. Carol Knightly is the director of the Center for Childhood Communication at Children's Hospital of Philadelphia. Her research areas of interest are hearing loss and 22q11.2 deletion.

Kobulsky joined the Kurre Lab in 2022 and is currently working to examine the impact of hematopoietic stem cell and progenitor cell-derived extracellular vesicles on the bone marrow microenvironment.

Dr. Kolon is an expert in the care of children with genital disorders and renal/bladder/prostate cancers. His expertise in pediatric urologic oncology includes optimizing organ-sparing surgery and preservation of fertility in oncology patients.

Narasaiah Kovuru’s research focuses on understanding the origins of hematopoietic failure/bone marrow failure in Fanconi Anemia working with the murine model.

Dr. Koyama's research focuses on Hereditary Multiple Exostoses (HME), a genetic disorder that causes the development of multiple benign tumors on the surface of the metaphyses of long bones. Based on his extensive knowledge of the normal processes of skeletal development and growth, Dr. Koyama's research aims to clarify the molecular mechanisms of HME formation and growth.

Responsible for the administrative leadership of the Center for Human Phenomic Science.

Dr. Krantz's lab identifies and characterizes the molecular etiology of syndromic and non-syndromic developmental disorders. He has identified genes for several genetic conditions (Cornelia de Lange Syndrome, CHOPS syndrome, Alagille syndrome, hearing loss) implicating critical molecular pathways in human disorders for the first time. He has been at the forefront of studying the integration of genomics into clinical settings.

Dr. Krishnaswamy studies molecular mechanisms underlying the reactions of blood coagulation. His laboratory investigates how the proteins of blood coagulation interact with each other and with membranes to yield a regulated clotting response to vascular injury or an unregulated response in thrombotic or bleeding disease.

Dr. Krivitzky's research focuses on cognitive, behavioral, and social outcomes in pediatric stroke and related vascular conditions. She also has an interest in studying outcomes in children and adults with inborn errors of metabolism.

Dr. Ku's research focuses on quality improvement in pediatric emergency medicine as well as clinical standards with implementation of clinical decision support to improve patient care.

Dr. Kumar's research focuses on strabismus, including clinical work on the surgical management of nystagmus and associated head posture. She's interested in evaluating strategies to minimize healthcare-associated exposure keratopathy, and to improve referral practices for patients diagnosed with congenital cataracts.

Dr. Kumar's research focuses on structure and function of proteins in blood coagulation. Using a coupled structural and biochemical approach, his lab studies molecular mechanisms underlying coagulation with a goal to understand how the tertiary structure determines the function of coagulation proteins

Dr. Kurre's laboratory has longstanding expertise in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With training in transplantation and hematopoietic stem cell biology, he hopes to improve the understanding of the progressive hematopoietic failure in patients with bone marrow failure and FA, broaden diagnostic approaches, and develop next generation therapies.

Dr. Kurth is a physician-scientist-leader in pediatric anesthesiology, quality and safety, and pediatric healthcare. He has experience conducting basic, clinical, and translational research studies as well as quality improvement projects to investigate clinical problems and develop technologies to understand the problem and devise therapies to prevent or treat it.

Dr. Kwiatkowski is director of the Thalassemia Center at CHOP. Her research focuses on gene therapy for hemoglobinopathies, monitoring and treatment of complications of thalassemia, sickle cell disease, pyruvate kinase deficiency, and monitoring and treatment of transfusional iron overload.